- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
SCR Market Currents
more »
-
May 9 Simcere Pharmaceutical (SCR): Q1 EPS of $0.08 in-line. Revenue of $77.4M (+5.2% Y/Y) misses by $7M. (PR)
Comment![Earnings, Healthcare]
SCR in Focus
more »
SCR Related Articles
more »
SCR News
more »
-
at MarketWatch.com (Apr 26, 2011)
-
at MarketWatch.com (Apr 26, 2011)
-
at MarketWatch.com (Apr 5, 2011)
-
at MarketWatch.com (Mar 14, 2011)
-
at MarketWatch.com (Mar 14, 2011)
SCR Press Releases and Filings
more »
-
PR Newswire (May 11, 2012)
-
PR Newswire (May 9, 2012)
-
PR Newswire (Apr 26, 2012)
-
PR Newswire (Apr 24, 2012)
SCR Latest Transcript
more »
-
Tue, Aug 18, 2009
SCR Cramer
more »
-
Tue, Apr 24, 2007
SCR Instablog posts
more »
SCR vs. ETF Alternatives
Company Description
Currently, there's no company description for SCR.
